Aflibercept for Retinopathy of Prematurity - Intravitreal Injection Versus Laser Therapy
Status:
Completed
Trial end date:
2021-02-12
Target enrollment:
Participant gender:
Summary
The purpose of this study is to demonstrate how well aflibercept works in babies with ROP,
comparing it with laser therapy. The study also has the objective to demonstrate how safe
aflibercept is when used in babies, and describe how the drug moves into, through and out of
the body.